During Friday’s Current trade, Shares of B2Gold Corp (NYSEMKT:BTG), lost -4.59% to $1.04.
B2Gold Corp (BTG) disclosed robust results from the Optimized Feasibility Study (OFS) of Fekola Gold Project, commencement of construction at Fekola in Mali and the closing of the previously announced $350 million Revolving Credit Facility. All dollar figures are in United States dollars unless otherwise indicated. All Fekola Project amounts are on a 100% ownership basis.
Highlights of the Optimized Fekola Feasibility Study
- Open pit gold mine with an initial production life of mine (“LOM”) of 12.5 years based on probable mineral reserves
- Average annual gold production for years one through seven of 350,000 ounces per year at a $418 operating cash cost per ounce
- Average annual LOM gold production of 276,000 ounces per year at an operating cash cost of $552 per ounce
- New open pit probable mineral reserves of 49.2 million tonnes at a grade of 2.35 grams per tonne (“g/t”) gold containing 3.72 million ounces of gold at a stripping ratio of 4.5:1
- Average LOM gold recovery of 92.8% resulting in a total of 3.45 million ounces produced over the 12.5 year life of mine
B2Gold Corp., a mid-tier gold mining company, explores and develops mineral properties in Nicaragua, the Philippines, Namibia, Burkina Faso, and Chile. The company principally explores for gold, silver, and copper. It primarily holds a 100% interest in the La Libertad mine, which comprises of an exploitation concession covering 10,950 hectares located in Nicaragua; a 95% interest in the Limon mine property that covers an area of 12,000 hectares located northwest of Managua; and has 95% interest in Limon gold mine located in northwestern Nicaragua. The company also has interest in the Masbate mine, an open pit gold mine located near the northern tip of the island of Masbate; has a 90% interest in the Fekola gold mine located in southwestern Mali; and has 81% interest in the Kiaka gold project located in Burkina Faso. B2Gold Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.
Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), declined -0.35% to $4.14, during its current trading session.
Arena Solutions, the pioneer of cloud-based product lifecycle administration (PLM) applications, recently declared that the number of new enterprise deals closed in Q2 2015 grew 75 percent contrast to the same period in 2014.
This figure demonstrates the continued strength and growth that Arena is experiencing in the enterprise sector. The need to connect to a wider array of global suppliers, ease of deployment and the desire for solutions that do not require additional hardware and IT resources continue to accelerate the demand for cloud PLM solutions.
In addition, as the number of enterprise transactions has grown, so has the demand for Arena’s professional services, which were up 110 percent in Q2 2015 over the same period last year. Even so, Arena’s PLM solutions still routinely require far fewer services than its legacy PLM competitors. Where Arena typically requires 25 cents of services for every dollar of new license subscription, most other PLM companies usually charge one to three dollars of services for every license dollar. Furthermore, Arena’s services come with a fixed price for implementation, as opposed to the unpredictable and uncapped ‘time and materials’ model used by others in the industry.
Other achievements in Q2 2015 over Q2 2014 comprise:
- A 42 percent enhance in the number of new customers;
- Subscription revenue for new customers up 54 percent;
- Customers expanding licenses or adding new products up 53 percent;
- Total subscription revenue up 27 percent, more than three times the PLM industry growth rate of 8.18 percent for 2011 - 2015, according to TechNavio.
Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight administration in adults. It is also developing a portfolio of programs in various therapeutic areas, counting cardiovascular, central nervous system, and metabolic diseases. Its products under development comprise Ralinepag, an agonist of the prostacyclin receptor intended for the treatment of vascular diseases, counting potentially pulmonary arterial hypertension that is in Phase II clinical trials.
Norfolk Southern Corp. (NYSE:NSC), during its Friday’s current trading session gained 0.57% to $83.96.
New Senior Investment Group Inc. (SNR) declared that it will release its second quarter 2015 financial results on Thursday, August 6, 2015 proceeding to the opening of trading on the New York Stock Exchange. A copy of the press release will be posted to the Investor Relations section of New Senior’s website, www.newseniorinv.com.
New Senior Investment Group Inc. (NYSE:SNR.WI) operates independently of Newcastle Investment Corp. as of November 6, 2014.
Finally, Allstate Corp (NYSE:ALL), gained 0.37%, to $68.60.
Builders FirstSource, Inc. (the “Company”) (BLDR) recently declared that it intends to offer, in a private offering subject to market and other conditions, $750.0 million aggregate principal amount of senior unsecured notes due 2023 (the “Notes”). The offering of the Notes is being made in connection with the Company’s formerly declared agreement to acquire all of the issued and outstanding equity interests of ProBuild Holdings, LLC, a Delaware limited liability company (“ProBuild”), following a Securities Purchase Agreement, dated as of April 13, 2015, between the Company, ProBuild and the holders of securities of ProBuild named as parties thereto (the “ProBuild Acquisition”). This offering is conditioned on the consummation of the ProBuild Acquisition.
Obligations under the Notes will initially be guaranteed by certain of the Company’s and ProBuild’s auxiliaries.
Builders FirstSource, Inc. manufactures and supplies structural and related building products for residential new construction primarily in the southern and eastern United States. The company offers prefabricated components, counting floor trusses, roof trusses, wall panels, stairs, and engineered wood; and window and door products, such as aluminum and vinyl windows, and pre-hung interior and exterior doors, in addition to assembles and distributes interior and exterior door units.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
